Impact of neutropenia on the outcome of decitabine (DAC) treatment in patients (pts) with myelodysplastic syndrome (MDS).

6605 Background: Pts with MDS often present with neutropenia. We investigated the effect of baseline neutropenia on outcome in pts treated with DAC for higher risk MDS. Methods: We reviewed 188 pts...